| 000 | 01712 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517084943.0 | ||
| 264 | 0 | _c20180110 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1591-9528 | ||
| 024 | 7 |
_a10.1007/s10238-016-0409-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTai, Cheng-Jeng | |
| 245 | 0 | 0 |
_aBevacizumab and cetuximab with conventional chemotherapy reduced pancreatic tumor weight in mouse pancreatic cancer xenografts. _h[electronic resource] |
| 260 |
_bClinical and experimental medicine _cMay 2017 |
||
| 300 |
_a141-150 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Immunological _xadministration & dosage |
| 650 | 0 | 4 |
_aBevacizumab _xadministration & dosage |
| 650 | 0 | 4 |
_aCetuximab _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDrug Therapy _xmethods |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHeterografts |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTumor Burden |
| 700 | 1 | _aWang, Hang | |
| 700 | 1 | _aWang, Chien-Kai | |
| 700 | 1 | _aTai, Chen-Jei | |
| 700 | 1 | _aHuang, Ming-Te | |
| 700 | 1 | _aWu, Chih-Hsiung | |
| 700 | 1 | _aChen, Ray-Jade | |
| 700 | 1 | _aKuo, Li-Jen | |
| 700 | 1 | _aWei, Po-Lei | |
| 700 | 1 | _aChang, Yu-Jia | |
| 700 | 1 | _aChang, Chun-Chao | |
| 700 | 1 | _aChiou, Hung-Yi | |
| 700 | 1 | _aWu, Chang-Jer | |
| 773 | 0 |
_tClinical and experimental medicine _gvol. 17 _gno. 2 _gp. 141-150 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10238-016-0409-2 _zAvailable from publisher's website |
| 999 |
_c25844946 _d25844946 |
||